Malignant ovarian tumors: conservative surgery and quality of life in young patients.
Better knowledge and adequate treatment of malignant ovarian tumors have improved the quality of life of young women--especially of child-bearing age. Nowadays preservation of ovarian function in women with tumors in early stage (I) or, in selected cases even in advanced stage (II-III), must be evaluated for conservative surgery (sometimes expressly requested by the patient herself). In our Institute we have followed this philosophy for many years and our experience confirms its value: 42 patients under age 40 (36 in stage I and 6 in advanced stage) underwent conservative surgery: 12 subsequently became pregnant and another 12 are able to conceive. Five- and ten-year survival rates are very good with 89.2% and 83.3% for all stages and 96.9% and 95% for early stages.
Marchetti
M
M
Department of Gynecology and Obstetrics, Padua University, Italy.
Padovan
P
P
Fracas
M
M
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000601:surgery*; D011788:Quality of Life; D015996:Survival Rate
D000970:Antineoplastic Agents